US$ 28.00
oral semaglutide for weight loss in non diabetics Study reveals 50 mg as promising treatment obesity adults: the Lancet report Rybelsus for Weight Loss -
Description
Guaranteed potency until expiration

Conclusion GLP-1 RA use was associated with substantially reduced all-cause death but a small increased risk of acute pancreatitis, particularly during early treatment

Reports of Ozempic mouth gum inflammation, tooth decay, and bad breath are emerging among people using GLP-1 drugs.
TLDR...I made it one month (barely)
